HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)

Human c1-esterase inhibitor · CSL Behring GmbH
PRESCRIPTION ONLY (USA)

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) ingredients

Active ingredientStrength
Human c1-esterase inhibitorsee label

What HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is used for

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)
Generic name
Human c1-esterase inhibitor
Made by
CSL Behring GmbH
Forms
Kit
FDA approval
Biologic licence (BLA) BLA125606
On the US market since
2017

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)?

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) (Human c1-esterase inhibitor) is a specialist medicine made by CSL Behring GmbH, approved by the US FDA.

What are the ingredients of HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)?

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) contains Human c1-esterase inhibitor.

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.